Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>CLSA: GALAXY ENT (00027.HK) 4Q25 Adj. EBITDA Beats; Firm Remains Sector Top Pick
Recommend 3 Positive 7 Negative 2 |
||||
|
||||
|
GALAXY ENT (00027.HK)'s 4Q25 adjusted EBITDA surged by 33% YoY to $4.3 billion, 3% ahead of both the expectations of CLSA/ the market, CLSA issued a research report saying. Final DPS increased by 60% to $0.8, with the full-year dividend payout ratio expanding by 1,100 bps to 61%. CLSA continued to believe that GALAXY ENT holds a competitive edge in the Macau market, effectively defending its market share, and anticipated further room for dividend growth. Therefore, the broker kept rating at Outperform for the Company and a target price of $49.5. The Company remains its sector top pick. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
